Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Karp

Showing results (41-50 of 336) with videos related to

Pageof 34
Sort By:
Current Opinion in Immunology|December 1, 1991
The nephritogenic immune responseS L Karp, S E Albert, E G Neilson
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1991
Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serumC L Karp, S J Turco, D L Sacks
Eye and Vision (London, England)|June 27, 2018
Optical coherence tomography for ocular surface and corneal diseases: a reviewNandini Venkateswaran, Anat Galor, Jianhua Wang, et al.
American Journal of Ophthalmology|November 25, 2018
Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous NeoplasiaNandini Venkateswaran, Carolina Mercado, Anat Galor, et al.
Annals of Neurology|February 9, 2002
Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 productionAdriana A Byrnes, Justin C McArthur, Christopher L Karp
Current Opinion in Ophthalmology|May 18, 2013
Topical chemotherapy for ocular surface squamous neoplasiaAfshan A Nanji, Fouad E Sayyad, Carol L Karp
Ophthalmology|May 31, 2001
Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2bC L Karp, J K Moore, R H Rosa
Cornea|January 2, 2007
Evaluation and treatment of children with ocular rosaceaKendall E Donaldson, Carol L Karp, Mark T Dunbar
Immunological Reviews|February 24, 2015
Tuberculosis vaccines: barriers and prospects on the quest for a transformative toolChristopher L Karp, Christopher B Wilson, Lynda M Stuart
Cornea|August 6, 2009
Intralesional interferon alpha-2b therapy for adnexal Kaposi sarcomaYousuf A Qureshi, Carol L Karp, Sander R Dubovy
Pageof 34

Showing results (41-50 of 336) with videos related to

Sort By:
Pageof 34
Current Opinion in Immunology|December 1, 1991
The nephritogenic immune responseS L Karp, S E Albert, E G Neilson
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1991
Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serumC L Karp, S J Turco, D L Sacks
Eye and Vision (London, England)|June 27, 2018
Optical coherence tomography for ocular surface and corneal diseases: a reviewNandini Venkateswaran, Anat Galor, Jianhua Wang, et al.
American Journal of Ophthalmology|November 25, 2018
Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous NeoplasiaNandini Venkateswaran, Carolina Mercado, Anat Galor, et al.
Annals of Neurology|February 9, 2002
Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 productionAdriana A Byrnes, Justin C McArthur, Christopher L Karp
Current Opinion in Ophthalmology|May 18, 2013
Topical chemotherapy for ocular surface squamous neoplasiaAfshan A Nanji, Fouad E Sayyad, Carol L Karp
Ophthalmology|May 31, 2001
Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2bC L Karp, J K Moore, R H Rosa
Cornea|January 2, 2007
Evaluation and treatment of children with ocular rosaceaKendall E Donaldson, Carol L Karp, Mark T Dunbar
Immunological Reviews|February 24, 2015
Tuberculosis vaccines: barriers and prospects on the quest for a transformative toolChristopher L Karp, Christopher B Wilson, Lynda M Stuart
Cornea|August 6, 2009
Intralesional interferon alpha-2b therapy for adnexal Kaposi sarcomaYousuf A Qureshi, Carol L Karp, Sander R Dubovy
Pageof 34